Suppr超能文献

相似文献

2
Therapeutic Modulation of the Immune Response in Arrhythmogenic Cardiomyopathy.
Circulation. 2019 Oct 29;140(18):1491-1505. doi: 10.1161/CIRCULATIONAHA.119.040676. Epub 2019 Sep 19.
3
Cardiac sympathetic neurons are additional cells affected in genetically determined arrhythmogenic cardiomyopathy.
J Physiol. 2025 Mar;603(7):1959-1982. doi: 10.1113/JP286845. Epub 2024 Aug 14.
4
Mitochondrial micro-calpain is not involved in the processing of apoptosis-inducing factor.
Exp Neurol. 2009 Aug;218(2):221-7. doi: 10.1016/j.expneurol.2009.04.013. Epub 2009 Apr 23.
5
Desmoglein 2-Dependent Arrhythmogenic Cardiomyopathy Is Caused by a Loss of Adhesive Function.
Circ Cardiovasc Genet. 2015 Aug;8(4):553-63. doi: 10.1161/CIRCGENETICS.114.000974. Epub 2015 Jun 17.
7
Calcium dysregulation induces apoptosis-inducing factor release: cross-talk between PARP-1- and calpain-signaling pathways.
Exp Neurol. 2009 Aug;218(2):213-20. doi: 10.1016/j.expneurol.2009.04.032. Epub 2009 May 7.
8
Critical role of calpain I in mitochondrial release of apoptosis-inducing factor in ischemic neuronal injury.
J Neurosci. 2007 Aug 29;27(35):9278-93. doi: 10.1523/JNEUROSCI.2826-07.2007.
10
Mechanisms of Innate Immune Injury in Arrhythmogenic Cardiomyopathy.
bioRxiv. 2023 Jul 13:2023.07.12.548682. doi: 10.1101/2023.07.12.548682.

引用本文的文献

1
PANoptosis in cancer: molecular mechanisms and therapeutic potential.
Cancer Gene Ther. 2025 Aug 21. doi: 10.1038/s41417-025-00940-6.
2
Mitochondrial Quality Control in Health and Disease.
MedComm (2020). 2025 Aug 15;6(8):e70319. doi: 10.1002/mco2.70319. eCollection 2025 Aug.
3
Qualitative analysis of experiences, burdens, and needs among patients with hypertrophic cardiomyopathy in Japan.
Future Cardiol. 2025 Aug;21(10):759-768. doi: 10.1080/14796678.2025.2526279. Epub 2025 Jul 11.
4
MicroRNAs at the crossroads of exercise and ferroptosis: a regulatory bridge.
Clin Exp Med. 2025 Jul 6;25(1):234. doi: 10.1007/s10238-025-01766-0.
5
Machine Learning Models Enhance Prediction of Arrhythmogenic Right Ventricular Cardiomyopathy.
medRxiv. 2025 Jun 17:2025.06.16.25329706. doi: 10.1101/2025.06.16.25329706.
6
Exercise Prescription in Arrhythmogenic Cardiomyopathy: Finding the Right Balance Between Risks and Benefits.
J Am Heart Assoc. 2025 Jun 17;14(12):e039125. doi: 10.1161/JAHA.124.039125. Epub 2025 Jun 5.
9
Medroxyprogesterone promotes neuronal survival after cerebral ischemic stroke by inhibiting PARthanatos.
Front Pharmacol. 2025 Feb 13;16:1487436. doi: 10.3389/fphar.2025.1487436. eCollection 2025.
10
Elamipretide: A Review of Its Structure, Mechanism of Action, and Therapeutic Potential.
Int J Mol Sci. 2025 Jan 23;26(3):944. doi: 10.3390/ijms26030944.

本文引用的文献

2
Inhibiting the interaction between apoptosis-inducing factor and cyclophilin A prevents brain injury in neonatal mice after hypoxia-ischemia.
Neuropharmacology. 2020 Jul;171:108088. doi: 10.1016/j.neuropharm.2020.108088. Epub 2020 Apr 8.
3
Therapeutic Modulation of the Immune Response in Arrhythmogenic Cardiomyopathy.
Circulation. 2019 Oct 29;140(18):1491-1505. doi: 10.1161/CIRCULATIONAHA.119.040676. Epub 2019 Sep 19.
7
Apoptosis-Inducing Factor (AIF) in Physiology and Disease: The Tale of a Repented Natural Born Killer.
EBioMedicine. 2018 Apr;30:29-37. doi: 10.1016/j.ebiom.2018.03.016. Epub 2018 Mar 23.
8
Phospho-Tau Bar Code: Analysis of Phosphoisotypes of Tau and Its Application to Tauopathy.
Front Neurosci. 2018 Feb 6;12:44. doi: 10.3389/fnins.2018.00044. eCollection 2018.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验